Status:
TERMINATED
Anticoagulation Length in Cancer Associated Thrombosis
Lead Sponsor:
Cardiff University
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Wales Cancer Trials Unit
Conditions:
Cancer
Thrombosis
Eligibility:
All Genders
16+ years
Phase:
PHASE2
Brief Summary
This is a two year, multicentre, mixed methods feasibility study including a randomised controlled two-arm interventional trial, a nested qualitative study, focus groups and a United Kingdom (UK) wide...
Detailed Description
Venous thromboembolism (VTE) is a term to describe blood clots in the legs known as a deep vein thrombus (DVT) or lung, known as a pulmonary embolus (PE). It is a common condition, which causes many s...
Eligibility Criteria
Inclusion
- Receiving LMWH for treatment of CAT for five months
- Locally advanced or metastatic cancer
- Able to self-administer LMWH, or have LMWH administered by a carer
- Able to give informed consent
- Age ≥16 years
Exclusion
- Receiving drug other than LMWH for CAT
- Contraindication to anticoagulation
- Fitted with a prosthetic heart valve
- Pregnant and/or lactating females
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT01817257
Start Date
December 1 2013
End Date
February 1 2015
Last Update
October 29 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
George Eliot Hospital NHS Trust (George Eliot Hospital)
Nuneaton, Warwickshire, United Kingdom
2
Worcestershire Acute Hospitals NHS Trust (Worcester Royal Hospital)
Worcester, Worcestershire, United Kingdom
3
Velindre NHS Trust (Velindre Cancer Centre)
Cardiff, United Kingdom
4
Aneurin Bevan Health Board (Royal Gwent Hospital)
Newport, United Kingdom